# Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations

> **NCT04378881** · — · UNKNOWN · sponsor: **Tabula Rasa HealthCare** · enrollment: 100 (estimated)

## Conditions studied

- COVID
- Drug Effect
- Drug Interaction
- Adverse Drug Event

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04378881
- **Lead sponsor:** Tabula Rasa HealthCare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-12
- **Primary completion:** 2023-06-11
- **Final completion:** 2023-11-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04378881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04378881, "Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04378881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*